Subscribe To
Repare therapeutics reveals early efficacy data from lead program in solid tumor setting
Repare Therapeutics Inc (NASDAQ: rptX) announced the presentation of preliminary Phase 1 monotherapy ...
October 11, 2021, 6:21 am
Repare therapeutics reveals early efficacy data from lead program in solid tumor setting
Repare Therapeutics Inc (NASDAQ: rptX) announced the presentation of preliminary Phase 1 monotherapy ...
October 11, 2021, 6:21 am
Repare therapeutics reveals early efficacy data from lead program in solid tumor setting
Repare Therapeutics Inc (NASDAQ: rptX) announced the presentation of preliminary Phase 1 monotherapy ...
October 11, 2021, 6:21 am
The moonshot investor: the insider track strategy
Excerpts of this article were originally published on October 4 and 18, 2021, as part of Tom Yeung's Mo...
October 8, 2021, 4:26 pm
The moonshot investor: the insider track strategy
Excerpts of this article were originally published on October 4 and 18, 2021, as part of Tom Yeung's Mo...
October 8, 2021, 4:26 pm
The moonshot investor: the insider track strategy
Excerpts of this article were originally published on October 4 and 18, 2021, as part of Tom Yeung's Mo...
October 8, 2021, 4:26 pm
Repare therapeutics presents preliminary phase 1 monotherapy clinical data from the ongoing first-in-human phase 1/2 tresr study of rp-3500 in solid tumors at aacr-nci-eortc international conference o
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...
October 8, 2021, 3:10 pm
Repare therapeutics presents preliminary phase 1 monotherapy clinical data from the ongoing first-in-human phase 1/2 tresr study of rp-3500 in solid tumors at aacr-nci-eortc international conference o
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...
October 8, 2021, 3:10 pm
Repare therapeutics presents preliminary phase 1 monotherapy clinical data from the ongoing first-in-human phase 1/2 tresr study of rp-3500 in solid tumors at aacr-nci-eortc international conference o
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...
October 8, 2021, 3:10 pm
Sarepta, codiak nix exosome therapy development pact
Sarepta Therapeutics Inc (NASDAQ: Srpt) notified Codiak BioSciences Inc (NASDAQ: CDAK) that it woul...
October 8, 2021, 1:02 pm
Sarepta, codiak nix exosome therapy development pact
Sarepta Therapeutics Inc (NASDAQ: Srpt) notified Codiak BioSciences Inc (NASDAQ: CDAK) that it woul...
October 8, 2021, 1:02 pm
Sarepta, codiak nix exosome therapy development pact
Sarepta Therapeutics Inc (NASDAQ: Srpt) notified Codiak BioSciences Inc (NASDAQ: CDAK) that it woul...
October 8, 2021, 1:02 pm
rptx stock: why it increased by over 17% today
The stock price of Repare Therapeutics Inc (NASDAQ: rptX) increased by over 17% during intraday trading...
October 8, 2021, 11:58 am
rptx stock: why it increased by over 17% today
The stock price of Repare Therapeutics Inc (NASDAQ: rptX) increased by over 17% during intraday trading...
October 8, 2021, 11:58 am
rptx stock: why it increased by over 17% today
The stock price of Repare Therapeutics Inc (NASDAQ: rptX) increased by over 17% during intraday trading...
October 8, 2021, 11:58 am
Repare therapeutics issues statement regarding inadvertent issuance of phase 1/2 tresr rp-3500 clinical trial abstract by the aacr-nci-eortc virtual international conference
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...
October 7, 2021, 5:08 pm
Repare therapeutics issues statement regarding inadvertent issuance of phase 1/2 tresr rp-3500 clinical trial abstract by the aacr-nci-eortc virtual international conference
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...
October 7, 2021, 5:08 pm
Repare therapeutics issues statement regarding inadvertent issuance of phase 1/2 tresr rp-3500 clinical trial abstract by the aacr-nci-eortc virtual international conference
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: ...
October 7, 2021, 5:08 pm